Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
Total Debt/Equity

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Total Debt/Equity History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Total Debt/Equity(x) 0.020.030.04--

What is the latest Total Debt/Equity ratio of GLAND PHARMA ?

The latest Total Debt/Equity ratio of GLAND PHARMA is 0.02 based on Mar2026 Consolidated results.
Year Total Debt/Equity
Mar20260.02
Mar20250.03
Mar20240.04
Mar2023-
Mar2022-

How is Total Debt/Equity of GLAND PHARMA Trending?

Years Total Debt/Equity % Change
Mar2026 0.02
-33.33
Mar2025 0.03
-25.00
Mar2024 0.04
0
Mar2023 0
0
Mar2022 0 -

Other Financial Ratios of GLAND PHARMA


Compare Total Debt/Equity ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹46,588.6 Cr -4.2% 14.4% 48.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,114.0 Cr -2.3% -3.3% 15.7% Stock Analytics
DIVIS LABORATORIES ₹227,958.0 Cr 0.3% 16.3% 44.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,990.0 Cr 2.8% -0.5% 37.1% Stock Analytics
CIPLA ₹116,141.0 Cr -3.1% -1.2% -5.8% Stock Analytics
DR REDDYS LABORATORIES ₹98,604.4 Cr -2.9% -3% -3.3% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-4.2%

14.4%

48.4%

SENSEX

-0.7%

0.1%

-3.4%


You may also like the below Video Courses